drugset / Trial / NCT05349149

IL-6 Regulation of Energy Stores During Recovery From an Acute Exercise Bout

NCT05349149

Completed 30 enrolled Helga Ellingsgaard
RandomizedParallel-groupDouble-blindBasic science

Summary

The aim of the study is to investigate the role of exercise-induced IL-6 in regulating energy stores and energy metabolism during recovery after an acute exercise bout. To achieve this, 30 men will be randomized to infusion placebo or tocilizumab (IL-6 receptor antibody) combined with a 2-hour exercise bout. Stable isotope tracers will be infused to determine substrate kinetics. Indirect calorimetry will be applied to determine substrate oxidation, and muscle biopsies will be taken to determine substrate uptake and storage.

Timeline

Start
2022-04-20
Primary completion
2022-10-11
Completion
2022-10-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tocilizumab Monoclonal antibody 8 mg/kg Intravenous

Indications

No indication recorded.